- Trials with a EudraCT protocol (23)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
23 result(s) found for: Musculoskeletal Diseases AND Knee Degenerative Disease AND Joint Diseases.
Displaying page 1 of 2.
EudraCT Number: 2013-003467-60 | Sponsor Protocol Number: M13-741 | Start Date*: 2014-06-11 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Phase 2a Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients with Knee Osteoarthritis | |||||||||||||
Medical condition: Adult male and female patients with mild to moderate, symptomatic, radiographic and inflammatory osteoarthritis of the knee | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) GB (Completed) NL (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004046-18 | Sponsor Protocol Number: CL3-12911-040 | Start Date*: 2012-02-23 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: Knee joint replacement over 5 years in patients with knee osteoarthritis. A long term follow up study in patients of the CL3-12911-018 study. | |||||||||||||
Medical condition: Osteoarthritis The medical condition investigated in the CL3-12911-018 study was osteoarthritis. The applied CL3-12911-040 trial, CL3-12911-018 follow-up study, is thus performed in osteoarthrit... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) DE (Prematurely Ended) AT (Completed) BE (Completed) PL (Prematurely Ended) ES (Prematurely Ended) IT (Prematurely Ended) DK (Prematurely Ended) LT (Prematurely Ended) PT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002963-92 | Sponsor Protocol Number: CLRX712A12201 | Start Date*: 2020-02-05 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A randomized, placebo-controlled, subject and investigator blinded study investigating the safety, tolerability and preliminary efficacy of 8-week treatment with intra-articular LRX712 to regenerat... | |||||||||||||
Medical condition: Cartilage injuries | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004049-26 | Sponsor Protocol Number: MTX-071-P02 | Start Date*: 2017-11-23 | |||||||||||
Sponsor Name:Mestex | |||||||||||||
Full Title: Lopain (MTX-071 / resiniferatoxin) An open label, single dose phase Ib/IIa study to determine the safety and clinical effects of intra-articular injections of low doses of Lopain (MTX-071) in pa... | |||||||||||||
Medical condition: chronic osteoarthritic knee-joint pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001689-41 | Sponsor Protocol Number: RR11/9858 | Start Date*: 2013-11-20 | ||||||||||||||||||||||||||
Sponsor Name:University of Leeds | ||||||||||||||||||||||||||||
Full Title: Pain Reduction with Oral Methotrexate in knee Osteoarthritis, a pragmatic phase III trial of Treatment Effectiveness | ||||||||||||||||||||||||||||
Medical condition: Knee osteoarthritis | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003232-31 | Sponsor Protocol Number: TDU11685-ACT12505 | Start Date*: 2011-11-03 | |||||||||||
Sponsor Name:sanofi-aventis recherche et développement | |||||||||||||
Full Title: A two part protocol to assess, using double blind placebo control, the safety, tolerability, and pharmacokinetics of ascending single doses of a new intra-articular administration formulation of SA... | |||||||||||||
Medical condition: KNEE OSTEOARTHRITIS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004581-10 | Sponsor Protocol Number: CL2-201086-002 | Start Date*: 2018-09-04 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: Efficacy and safety of 3 doses of S201086/GLPG1972 administered orally once daily in patients with knee osteoarthritis. A 52-week international, multi-regional, multi-center, randomized, double-bli... | |||||||||||||
Medical condition: Osteoarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) HU (Completed) DK (Completed) PL (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003154-80 | Sponsor Protocol Number: 2020CLI | Start Date*: 2020-12-08 | |||||||||||
Sponsor Name:Mucos Pharma GmbH & Co. KG | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled, Crossover Study to Investigate the Mechanism of Action of an Oral Enzyme Treatment with Bromelain, Trypsin and Rutoside versus Placebo in Subjects wi... | |||||||||||||
Medical condition: Subjects suffering from knee Osteoarthitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004313-41 | Sponsor Protocol Number: 47659 | Start Date*: 2014-05-19 | |||||||||||||||||||||
Sponsor Name:UMCG | |||||||||||||||||||||||
Full Title: Effect of pre-operative pain treatment by means of duloxetine on postoperative outcome after total hip or knee arthroplasty | |||||||||||||||||||||||
Medical condition: Osteoarthritis (knee or hip) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001981-24 | Sponsor Protocol Number: MTX-071-P01 | Start Date*: 2016-02-04 | |||||||||||||||||||||
Sponsor Name:Mestex | |||||||||||||||||||||||
Full Title: Lopain (MTX-071 / resiniferatoxin) An open label, dose-escalating phase I/IIa study to determine the safety and clinical effects of intra-articular injections of Lopain (MTX-071) in patients wi... | |||||||||||||||||||||||
Medical condition: Chronic osteoarthritic knee-joint pain | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: BE (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-000818-37 | Sponsor Protocol Number: MTX-071-P03 | Start Date*: 2018-06-28 | |||||||||||||||||||||
Sponsor Name:Grünenthal GmbH | |||||||||||||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, single dose phase IIb exploratory study to document the clinical effects and safety of intra-articular injections of Lopain (MTX-071) in patients wit... | |||||||||||||||||||||||
Medical condition: chronic osteoarthritic knee joint pain | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: AT (Completed) SK (Completed) HR (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-004805-34 | Sponsor Protocol Number: TDU13828-ACT13830 | Start Date*: 2015-04-02 | |||||||||||
Sponsor Name:Sanofi-aventis Research & Development | |||||||||||||
Full Title: A Two Part Protocol Using Double Blind Placebo Control to Assess the Safety, Tolerability, and Pharmacokinetics of Single Escalating Intra-articular Doses Followed by Assessment of Efficacy, Safety... | |||||||||||||
Medical condition: Osteoarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003797-51 | Sponsor Protocol Number: D5680C00003 | Start Date*: 2021-07-20 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Randomised, Double-blind, Placebo-controlled, Dose-response Study of the Efficacy and Safety of MEDI7352 in Subjects with Painful Osteoarthritis of the Knee | |||||||||||||
Medical condition: Painful osteoarthritis of the knee | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002494-75 | Sponsor Protocol Number: CL3-12911-018 | Start Date*: 2006-04-26 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: The efficacy and safety of two doses of strontium ranelate (1g and 2g per day) versus placebo administered orally for 3 years in the treatment of knee osteoarthritis. A prospective multicentre, int... | |||||||||||||
Medical condition: Osteoarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) BE (Completed) GB (Completed) ES (Completed) IT (Completed) DK (Completed) PT (Completed) LT (Completed) EE (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004052-30 | Sponsor Protocol Number: CLNA043X2202 | Start Date*: 2017-04-28 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A randomized, placebo-controlled, patient and investigator blinded, Proof of Concept study investigating the safety, tolerability and preliminary efficacy of multiple intra-articular LNA043 injecti... | |||||||||||||
Medical condition: Acute cartilage injuries | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) CZ (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022556-23 | Sponsor Protocol Number: KF6005/03 | Start Date*: 2011-04-28 | ||||||||||||||||
Sponsor Name:Grünenthal GmbH | ||||||||||||||||||
Full Title: Estudio fase IIa, randomizado, de 4 semanas, en el que se evalúa la eficacia, seguridad y tolerabilidad de GRT6005, un nuevo analgésico de acción central, en pacientes con dolor moderado a severo d... | ||||||||||||||||||
Medical condition: Dolor debido a osteoartritis de rodilla | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) AT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-001619-62 | Sponsor Protocol Number: 12EU/Ct06 | Start Date*: 2014-02-10 |
Sponsor Name:IBSA, Institut Biochimique S.A. | ||
Full Title: A multicentre, comparative, randomised, double-blind, double-dummy clinical trial on the efficacy and safety of Condrosulf® versus Celebrex® and versus a placebo in the treatment of knee osteoarthr... | ||
Medical condition: knee osteoarthritisi, the most common form of arthritis and a leading cause of morbidity and disability | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) BE (Completed) CZ (Completed) PL (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-002081-39 | Sponsor Protocol Number: CLI/22 | Start Date*: 2019-03-14 | |||||||||||
Sponsor Name:Abiogen Pharma S.p.A. | |||||||||||||
Full Title: A randomised, double-blind, parallel-group, multicenter, placebo-controlled, dose-ranging study, to evaluate the efficacy and safety of clodronate ampoules at different dosages, after intra-articul... | |||||||||||||
Medical condition: knee osteoarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Prematurely Ended) CZ (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004796-39 | Sponsor Protocol Number: PT-SM-14-OA | Start Date*: 2013-04-30 | ||||||||||||||||
Sponsor Name:Fondazione IRCCS Policlinico San Matteo | ||||||||||||||||||
Full Title: A Comparative Study of Oxycodone/Naloxone versus Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Knee and/or hip Pain Due to Osteoarthritis | ||||||||||||||||||
Medical condition: Moderate to Severe Chronic Knee and/or hip Pain Due to Osteoarthritis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001769-34 | Sponsor Protocol Number: 102-240-02 | Start Date*: 2012-10-02 | ||||||||||||||||
Sponsor Name:AnaMar AB | ||||||||||||||||||
Full Title: A double-blind, placebo controlled, parallel-group, randomised study of safety, tolerability and efficacy of AMAP102 in patients with osteoarthritis. | ||||||||||||||||||
Medical condition: Osteoarthritis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Completed) DE (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
